Brief: Merck Is In Advanced Talks To Buy Harpoon Therapeutics- Bloomberg News
Jan 7 (Reuters) -
* MERCK IS IN ADVANCED TALKS TO BUY HARPOON THERAPEUTICS-
BLOOMBERG NEWS
* MERCK IS IN ADVANCED TALKS TO ACQUIRE CANCER DRUGMAKER
HARPOON
THERAPEUTICS FOR AROUND $700 MILLION - BLOOMBERG NEWS
* MERCK IS DISCUSSING PAYING ABOUT $23 A SHARE FOR HARPOON-
BLOOMBERG NEWS
Source text: http://tinyurl.com/5ap5mwmk
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals